Barclays
ANAB icon

Barclays’s AnaptysBio ANAB Stock Holding History

Barclays’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,000
Closed -$676K – 4842
2024
Q1 		$676K Buy
+30,000
New +$710K ﹤0.01% 3401
2021
Q2 		– Sell
-3,500
Closed -$75K – 4860
2021
Q1 		$75K Buy
+3,500
New +$88.3K ﹤0.01% 4102
2018
Q4 		– Sell
-97,300
Closed -$9.71M – 6903
2018
Q3 		$9.71M Buy
+97,300
New +$8.07M 0.01% 1281

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays's ANAB Position: Q1 2026 in Review

Barclays reduced its AnaptysBio (ANAB) stake by 88% in Q1 2026, selling an estimated $2.81M and leaving 7,440 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #3295.

Barclays first reported a position in ANAB in Q1 2017 and has held it in 37 quarters since. The position peaked at $12.4M in Q3 2018. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Barclays held 7,440 shares of AnaptysBio worth $413K as of Q1 2026.
  • Barclays sold 52,214 AnaptysBio shares in Q1 2026, an estimated $2.81M.
  • AnaptysBio made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3295 holding.
  • Barclays first reported a position in AnaptysBio in Q1 2017 and has held it in 37 quarters since.
  • Barclays's AnaptysBio position peaked at $12.4M in Q3 2018.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.